RSS Feeds
Search

Companies

Companies

Displaying 1..7 of 7 - per page
Order by
Active Biotech
Active Biotech AB is a Swedish biotech company focusing on the research and development of pharmaceuticals, primarily for the treatment of autoimmune / inflammatory diseases and cancer. More
Bioneer A/S
Bioneer is a CRO research based company within recombinant protein production, immuno-regulatory assays, drug characterization and formulation and diagnostic biomarkers. More
BTG
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. More
Queen Mary, University of London
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Farmacija d.o.o.
Farmacija is a pharmaceutical company focusing on the discovery and development of innovative peptide-based drugs, primarily for the treatment of auto-immune and inflammatory diseases. More
DeveloGen
A drug discovery company developing novel therapies for metabolic disorders, such as obesity and diabetes. More
CallistoGen AG
More
Displaying 1..7 of 7 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
AC Immune SA – Product Pipeline Review – Q4 2010
Dec 2010 - 37 pages - $500
National Institute of Neurological Disorders and Stroke – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Primary Immune Deficiency (PID) - Pipeline Review, Q1 2011
Jan 2011 - 34 pages - $500
Immunomodulators
Aug 2007 - 345 pages - $2,875
Immune Network, Ltd. - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Sleep Disorders - Pipeline Review, Q3 2011
Jul 2011 - 136 pages - $500
Acne And Related Disorders - Pipeline Review, H2 2011
Sep 2011 - 146 pages - $500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Immune Thombocytopenic Purpura (ITP) - Pipeline Review, Q4 2010
Dec 2010 - 55 pages - $500
Panic Disorders - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us